- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04522453
E-MhGAP Intervention Guide in Low- and Middle-income Countries: Proof-of-concept for Impact and Acceptability (EMILIA)
Study Overview
Status
Conditions
Detailed Description
Mental illnesses are common, affecting one in every three people during their lifetimes. Globally, mental illnesses are the leading contributor of years lived with a disability. Despite the prevalence and impact of mental illness, a large difference between true and treated prevalence rates of mental disorders, also known as the mental health treatment gap, exists. It is estimated that more than 80% of people with severe mental illness in low and middle-income countries receive no treatment. Only 16.5% of people with depression living in low- and middle-income countries have access to minimally adequate treatment. The consequences of this treatment gap include symptom persistence and deterioration, social exclusion, and long-term disability of people who could be economically productive and socially included. Globally, there is growing recognition of the importance of mental health as evidenced by its inclusion in the 2030 United Nations Agenda for Sustainable Development and extension of the World Health Organization Comprehensive Mental Health Action Plan to 2030 by the World Health Assembly.
Limited numbers of mental health specialists and the concentration of care in hospital settings limits the availability and accessibility of care. Low treatment rates in low- and middle-income countries are related to poor demand and supply-side forces. High levels of stigma associated with mental illness manifest in low rates of help-seeking among those who would benefit from care. The World Health Organization recommends a task-shifting approach to strengthen the generalist workforce and improve access to health care, including mental health care. However, this requires the availability of evidence-based tools and appropriate training, supervision, and support.
In recent years there has been an exponential rise in global access to mobile technologies in low- and middle-income countries. In 2012 there were 287 million unique mobile phone subscribers across sub-Saharan Africa covering 32% of the population. Six years later, that number rose to 465 million representing 44% of the population. In Nepal, the number of mobile contracts surpasses the total population (26.49 million). The increased application of mobile technology to healthcare arena, known as mobile health (mobile-health), aims to provide a powerful platform to improve the quality of interventions employing a task-shifting approach and reduce the treatment gap. Mobile health (mobile-health) refers to the use of mobile technology in health interventions and service provision. In a recent World Health Organization survey, 87% of responding countries reported at least one government sponsored mobile-health programme in their country. However, only 14% of countries reported an evaluation of these programmes, raising concerns about insufficient evidence of impact.
A systematic review of smartphone use in clinical decision making by healthcare professionals identified seven randomised control trials conducted in high-income settings, which demonstrated improved knowledge, diagnosis, treatment decisions and documentation using mobile-health technology. Studies on mobile-health tools in low- and middle-income countries have had more mixed results. Improved compliance to protocols has been demonstrated with a smart phone tool in India. Conversely, a study in Uganda failed to show improvement in service user outcomes when community-based peer workers used mobile phones to communicate with supervisors. Qualitative data does, however, suggest the intervention facilitated task shifting and improved health worker morale.
In 2010, the World Health Organization launched the Mental Health Gap Action Programme Intervention Guide, an evidence-based assessment and management guide for mental, neurological and substance use conditions designed for use by primary and community health staff in low- and middle-income countries. The first edition of the mental health Gap Action Program-Intervention Guide has been implemented in over 100 countries. An updated version was launched in 2016 with new sections and updated evidence-based guidance. The mental health Gap Action Program-Intervention Guide v2.0 consists of eight modules addressing priority conditions (i.e. depression, psychoses, epilepsy, child and adolescent mental and behavioural disorders, dementia, disorders due to substance use, self-harm/suicide and conditions related to extreme stress). The guide provides an overview of common presentations for each condition followed by detailed guidance for assessment, management (including referral to specialist care) and follow-up.
The E-mental health Gap Action Program Intervention guide in Low and middle-income countries: proof-of-concept for Impact and Acceptability (Emilia) project seeks to re-address the treatment gap by developing a potentially practicable way for primary health care staff to monitor and treat people with mental illness according to evidence-based guidelines. The project is comprised of three phases: (1) development of an adapted e-mental health Gap Action Program intervention guide, (2) feasibility testing, and (3) knowledge transfer and future work.
Objectives
Emilia aims to test the feasibility of an electronic version of the mental health Gap Action Program-Intervention Guide v2.0 and trial procedures for the future evaluation of a large-scale trial, which would evaluate differences in depression detection between facilities using e-mental health Gap Action Program vs. paper mental health Gap Action Program. The objectives of this feasibility study, in preparation for a future trial, include the following:
- To evaluate the feasibility and acceptability of primary care mental health services utilizing the e-mental health Gap Action Program-Intervention Guide for training, supervision, and delivery of care [primary objective];
- To determine recruitment and retention rates for primary care workers and patients;
- To establish the acceptability and feasibility of assessing primary health worker and patient outcomes;
- To assess ethics and safety procedures using adverse event reporting;
- To describe depression detection rates in primary health clinics; and
- To describe depression treatment outcomes in primary health clinics.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Primary Care Health Workers: Primary healthcare staff will be eligible to participate if they are employed by the primary care clinic or government and have roles and responsibilities that relate to the use of the mental health Gap Action Program (e.g. direct clinical use or supervision). All relevant primary care staff, regardless of individual study participation, will receive training in the mental health Gap Action Program. (electronic or paper version) and have ongoing remote support and supervision.
- Patients: Attending primary care for treatment; fluent in Nepali (for Nepal site) or Yoruba (for Nigeria site);
Exclusion Criteria:
- Primary Care Health Workers: No exclusion criteria.
- Patients: Adult attendees will be deemed ineligible for the study if they are unable to understand or complete study assessment (e.g. individuals with severe learning disability or dementia), unable give informed consent, or have a medical emergency requiring immediate intervention.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: paper mental health Gap Action Program-Intervention Guide
This arm will be training and supervision as usual employing the standard paper version of the mental health Gap Action Program-Intervention Guide.
Primary care workers will be trained to use the paper version of this tool and will use the paper version when evaluating patients.
|
A paper-based guide for diagnosis and management of mental disorders in primary care.
|
|
EXPERIMENTAL: digital mental health Gap Action Program-Intervention Guide
This arm will be training and supervision in an experimental approach using a digital version of version of the mental health Gap Action Program-Intervention Guide.
The digital version allows for interactive decision making on diagnoses and care, and it allows for entering of patient data.
Primary care workers in this arm will be trained to use the digital version of this tool and will use the digital version when evaluating patients.
|
A digital guide and client data entry tool for diagnosis and management of mental disorders in primary care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mental Health Gap Action Programme Depression Diagnosis Tool
Time Frame: Three months post training
|
Unnabbreviated name of scale: "Mental Health Gap Action Programme Depression Diagnosis Tool"; Primary care health workers diagnosis of depression documented in clinical records; Unit of measure: % of patients with Mental Health Gap Action Programme Depression Diagnosis compared to number of patients with positive Patient Health Questionnaire depression screen
|
Three months post training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mental Health Gap Action Programme Depression Diagnosis Tool
Time Frame: One month prior to training
|
Unnabbreviated name of scale: "Mental Health Gap Action Programme Depression Diagnosis Tool"; Primary care health workers diagnosis of depression documented in clinical records; Unit of measure: % of patients with Mental Health Gap Action Programme Depression Diagnosis compared to number of patients with positive Patient Health Questionnaire depression screen
|
One month prior to training
|
|
Patient health questionnaire 9
Time Frame: One month prior to training
|
Unabbreviated scale title "Patient health questionnaire 9"; Self reported symptoms of depression; minimum 0, maximum 27; high score is worse outcome
|
One month prior to training
|
|
Patient health questionnaire 9
Time Frame: Three months post training
|
Unabbreviated scale title "Patient health questionnaire 9"; Self reported symptoms of depression; minimum 0, maximum 27; high score is worse outcome
|
Three months post training
|
|
Patient health questionnaire 9
Time Frame: Six months post training
|
Unabbreviated scale title "Patient health questionnaire 9"; Self reported symptoms of depression; minimum 0, maximum 27; high score is worse outcome
|
Six months post training
|
|
World Health Organization Disability Assessment Schedule
Time Frame: One month pre training
|
Unabbreviated name of scale: "World Health Organization Disability Assessment Schedule"; Self reported measure of functional impairment; Minimum score 0, Maximum 60; higher score is worse outcome
|
One month pre training
|
|
World Health Organization Disability Assessment Schedule
Time Frame: Three months post training
|
Unabbreviated name of scale: "World Health Organization Disability Assessment Schedule"; Self reported measure of functional impairment; Minimum score 0, Maximum 60; higher score is worse outcome
|
Three months post training
|
|
World Health Organization Disability Assessment Schedule
Time Frame: Six months post training
|
Unabbreviated name of scale: "World Health Organization Disability Assessment Schedule"; Self reported measure of functional impairment; Minimum score 0, Maximum 60; higher score is worse outcome
|
Six months post training
|
|
Mental health gap action program knowledge assessment
Time Frame: One day pre training
|
Unabbreviated scale title: "Mental health gap action program knowledge assessment"; Multiple choice test of mental disorder diagnosis and management; Minimum score 0%, Maximum 100%, higher score is better outcome
|
One day pre training
|
|
Mental health gap action program knowledge assessment
Time Frame: One day post training
|
Unabbreviated scale title: "Mental health gap action program knowledge assessment"; Multiple choice test of mental disorder diagnosis and management; Minimum score 0%, Maximum 100%, higher score is better outcome
|
One day post training
|
|
Mental health gap action program knowledge assessment
Time Frame: Three months post training
|
Unabbreviated scale title: "Mental health gap action program knowledge assessment"; Multiple choice test of mental disorder diagnosis and management; Minimum score 0%, Maximum 100%, higher score is better outcome
|
Three months post training
|
|
Mental health gap action program knowledge assessment
Time Frame: Eight months post training
|
Unabbreviated scale title: "Mental health gap action program knowledge assessment"; Multiple choice test of mental disorder diagnosis and management; Minimum score 0%, Maximum 100%, higher score is better outcome
|
Eight months post training
|
|
Enhancing Assessment of Common Therapeutic Factors
Time Frame: One day pre training
|
Unabbreviated title: "Enhancing Assessment of Common Therapeutic Factors"; Objective structured clinical examination of common factors and diagnostic practices; Minimum=15, Maximum=60; higher score is better outcome
|
One day pre training
|
|
Enhancing Assessment of Common Therapeutic Factors
Time Frame: One day post training
|
Unabbreviated title: "Enhancing Assessment of Common Therapeutic Factors"; Objective structured clinical examination of common factors and diagnostic practices; Minimum=15, Maximum=60; higher score is better outcome
|
One day post training
|
|
Enhancing Assessment of Common Therapeutic Factors
Time Frame: Three months post training
|
Unabbreviated title: "Enhancing Assessment of Common Therapeutic Factors"; Objective structured clinical examination of common factors and diagnostic practices; Minimum=15, Maximum=60; higher score is better outcome
|
Three months post training
|
|
Enhancing Assessment of Common Therapeutic Factors
Time Frame: Eight months post training
|
Unabbreviated title: "Enhancing Assessment of Common Therapeutic Factors"; Objective structured clinical examination of common factors and diagnostic practices; Minimum=15, Maximum=60; higher score is better outcome
|
Eight months post training
|
|
Social Distance Scale
Time Frame: One day pre training
|
Unabbreviated scale title: "Social Distance Scale"; Self reported measure of stigma against persons with mental illness; Minimum score=12, Maximum Score=72; higher score is worse outcome
|
One day pre training
|
|
Social Distance Scale
Time Frame: One day post training
|
Unabbreviated scale title: "Social Distance Scale"; Self reported measure of stigma against persons with mental illness; Minimum score=12, Maximum Score=72; higher score is worse outcome
|
One day post training
|
|
Social Distance Scale
Time Frame: Three months post training
|
Unabbreviated scale title: "Social Distance Scale"; Self reported measure of stigma against persons with mental illness; Minimum score=12, Maximum Score=72; higher score is worse outcome
|
Three months post training
|
|
Social Distance Scale
Time Frame: Eight months post training
|
Unabbreviated scale title: "Social Distance Scale"; Self reported measure of stigma against persons with mental illness; Minimum score=12, Maximum Score=72; higher score is worse outcome
|
Eight months post training
|
|
Enhancing Assessment of Common Therapeutic Factors - patient version
Time Frame: One month pre training
|
Unabbreviated scale title: "Enhancing Assessment of Common Therapeutic Factors - patient version"; Patient report of primary care workers common factors skills; minimum score=0, maximum score=15; higher score is better outcome
|
One month pre training
|
|
Enhancing Assessment of Common Therapeutic Factors - patient version
Time Frame: Three months post training
|
Unabbreviated scale title: "Enhancing Assessment of Common Therapeutic Factors - patient version"; Patient report of primary care workers common factors skills; minimum score=0, maximum score=15; higher score is better outcome
|
Three months post training
|
|
Enhancing Assessment of Common Therapeutic Factors - patient version
Time Frame: Six months post training
|
Unabbreviated scale title: "Enhancing Assessment of Common Therapeutic Factors - patient version"; Patient report of primary care workers common factors skills; minimum score=0, maximum score=15; higher score is better outcome
|
Six months post training
|
|
Acceptability of Intervention Measure
Time Frame: Three months post training
|
Unabbreviated scale title "Acceptability of Intervention Measure"; Subjective report of acceptability of intervention; A 5-item scale that measures the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory.
Minimum=5, Maximum=25; higher score is better
|
Three months post training
|
|
Acceptability of Intervention Measure
Time Frame: Eight months post training
|
Unabbreviated scale title "Acceptability of Intervention Measure"; Subjective report of acceptability of intervention; A 5-item scale that measures the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory.
Minimum=5, Maximum=25; higher score is better
|
Eight months post training
|
|
Acceptability of Intervention Measure - patient version
Time Frame: Six months post training
|
Unabbreviated scale title "Acceptability of Intervention Measure"; Subjective report of acceptability of intervention; A 5-item scale that measures the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory.
Minimum=5, Maximum=25; higher score is better
|
Six months post training
|
|
Feasibility of Intervention Measure
Time Frame: Three months post training
|
Unabbreviated title: " Feasibility of Intervention Measure"; Subjective report of feasibility of intervention; measures the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting.
Minimum=5, Maximum=25; higher score is better
|
Three months post training
|
|
Feasibility of Intervention Measure
Time Frame: Eight months post training
|
Unabbreviated title: " Feasibility of Intervention Measure"; Subjective report of feasibility of intervention; measures the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting.
Minimum=5, Maximum=25; higher score is better
|
Eight months post training
|
|
Intervention Appropriateness Measure
Time Frame: Three months post training
|
Unabbreviated title: " Intervention Appropriateness Measure"; Subjective report of appropriateness of intervention; A 5-item scale that measures the perceived fit, relevance, or compatibility of the innovation or evidence-based practice for a given practice setting, provider, or consumer, and/or perceived fit of the innovation to address a particular issue or problem.
Minimum=5, Maximum=25; higher score is better
|
Three months post training
|
|
Intervention Appropriateness Measure
Time Frame: Eight months post training
|
Unabbreviated title: " Intervention Appropriateness Measure"; Subjective report of appropriateness of intervention; A 5-item scale that measures the perceived fit, relevance, or compatibility of the innovation or evidence-based practice for a given practice setting, provider, or consumer, and/or perceived fit of the innovation to address a particular issue or problem.
Minimum=5, Maximum=25; higher score is better
|
Eight months post training
|
|
Intervention Appropriateness Measure - patient version
Time Frame: Six months post training
|
Unabbreviated title: " Intervention Appropriateness Measure"; Subjective report of appropriateness of intervention; A 5-item scale that measures the perceived fit, relevance, or compatibility of the innovation or evidence-based practice for a given practice setting, provider, or consumer, and/or perceived fit of the innovation to address a particular issue or problem.
Minimum=5, Maximum=25; higher score is better
|
Six months post training
|
|
Organizational Readiness for Implementing Change
Time Frame: One day pre training
|
Unabbreviated title: "Organizational Readiness for Implementing Change"; Subjective report of readiness for implementing a new intervention; a 16-item tool to assess Assesses perspectives on intra- and extra-organizational implementation readiness; minimum=16, maximum=90; higher score is better
|
One day pre training
|
|
Normalization Measure Development
Time Frame: Eight months post-training
|
Unabbreviated title: "Normalization Measure Development"; Subjective report of normalization of measure development; a brief self-report questionnaire that could be helpful in measuring implementation progress.
Based on the Normalization Process Theory, this instrument focuses on 4 generative mechanisms involved in implementation processes: coherence, cognitive participation, collective action, and reflexive monitoring.
20 items; minimum=20, maximum=100, higher score is better outcome
|
Eight months post-training
|
|
Perceptions of supervisory support scale
Time Frame: Eight months post-training
|
Unabbreviated title: "Perceptions of supervisory support scale"; Health workers perception of supervision support; 19 items, minimum score=19, maximum score=95; higher score is better outcome
|
Eight months post-training
|
|
Depression Attitudes Questionnaire
Time Frame: One day pre training
|
Unabbreviated title:"Depression Attitudes Questionnaire"; Health workers report of attitudes toward depression care; Minimum=10; Maximum=40, higher scores=better outcome
|
One day pre training
|
|
Depression Attitudes Questionnaire
Time Frame: One day post training
|
Unabbreviated title:"Depression Attitudes Questionnaire"; Health workers report of attitudes toward depression care; Minimum=10; Maximum=40, higher scores=better outcome
|
One day post training
|
|
Depression Attitudes Questionnaire
Time Frame: One month post training
|
Unabbreviated title:"Depression Attitudes Questionnaire"; Health workers report of attitudes toward depression care; Minimum=10; Maximum=40, higher scores=better outcome
|
One month post training
|
|
Depression Attitudes Questionnaire
Time Frame: Three months post training
|
Unabbreviated title:"Depression Attitudes Questionnaire"; Health workers report of attitudes toward depression care; Minimum=10; Maximum=40, higher scores=better outcome
|
Three months post training
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Graham Thornicroft, MD, PhD, King's College London
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MR/R023697/1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
-
Bekelu Teka WorkuJimma UniversityNot yet recruitingPrenatal Depression | Mental Health Related Quality of Life | Maternal Postpartum Depression | Paternal Postpartum DepressionEthiopia
Clinical Trials on paper-based version of mental health Gap Action Program-Intervention Guide
-
Sun Yat-sen UniversityZhongshan Boai HospitalRecruitingNeurodevelopmental DisordersChina
-
George Washington UniversityKing's College London; Duke University; World Health Organization; Transcultural...CompletedDepression | Psychological Distress | Posttraumatic Stress DisorderNepal
-
George Washington UniversityKing's College London; Duke University; World Health Organization; Transcultural...Completed
-
The Hong Kong Polytechnic UniversityHospital Authority, Hong KongCompleted
-
Northwestern UniversityNational Institute of Mental Health (NIMH)Not yet recruitingDepression | Anxiety | Nonsuicidal Self-injury
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate...United States
-
University of California, IrvineJacobs FoundationCompletedDepression | Stress | Anxiety | Loneliness | Distress, Emotional | Mental Health IssueUnited States
-
Johns Hopkins UniversityCatalyst FoundationCompletedAortic Valve Disease | Aortic Valve ReplacementUnited States
-
Xiaowan LiNot yet recruiting
-
Northwestern UniversityNational Cancer Institute (NCI); National Institute of Nursing Research (NINR)RecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States